Septerna (SEPN) Capital Expenditures (2023 - 2026)
Septerna (SEPN) posted quarterly Capital Expenditures of $832000.0 for Q1 2026, up 117.8% year-over-year from $382000.0 in Q1 2025, and up 1180.0% quarter-over-quarter from $65000.0 in Q4 2025.
Septerna (SEPN) Capital Expenditures (2023 - 2026) Analysis & Trends
Septerna's Capital Expenditures history runs 4 years deep, the most recent figure standing at $832000.0 for Q1 2026.
- In Q1 2026, Capital Expenditures rose 117.8% year-over-year to $832000.0; the TTM figure through Mar 2026 stood at $968000.0 (down 43.75% YoY), while the FY2025 annual figure was $518000.0, down 75.37% from the prior year.
- Capital Expenditures for Q1 2026 stood at $832000.0, up from $65000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $1.2 million in Q4 2023, with the low at $13000.0 in Q3 2025.
- The 4-year median for Capital Expenditures is $480000.0 (2024), against an average of $469200.0.
- The sharpest annual moves came in 2025 and 2026: Capital Expenditures sank 97.75% in 2025, then surged 117.8% in 2026.
- Septerna's Capital Expenditures stood at $1.2 million in 2023, then slumped by 50.61% to $612000.0 in 2024, then slumped by 89.38% to $65000.0 in 2025, then surged by 1180.0% to $832000.0 in 2026.
- Business Quant data shows SEPN's Capital Expenditures at $832000.0 in Q1 2026, $65000.0 in Q4 2025, and $13000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.29 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.02 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 572,662.23 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 251.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 34.68 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Septerna | 2.08 Bn | 2.08 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 832,000.00 |
| Mar 31, 2026 | 832,000.00 |
| Dec 31, 2025 | 65,000.00 |
| Dec 31, 2025 | 65,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 58,000.00 |
| Jun 30, 2025 | 58,000.00 |
| Mar 31, 2025 | 382,000.00 |
| Mar 31, 2025 | 382,000.00 |
| Dec 31, 2024 | 612,000.00 |
| Dec 31, 2024 | 612,000.00 |
| Sep 30, 2024 | 578,000.00 |
| Sep 30, 2024 | 578,000.00 |
| Jun 30, 2024 | 149,000.00 |
| Jun 30, 2024 | 149,000.00 |
| Mar 31, 2024 | 764,000.00 |
| Mar 31, 2024 | 764,000.00 |
| Dec 31, 2023 | 1.24 Mn |
| Dec 31, 2023 | 1.24 Mn |